Across the spectrum of human afflictions—from cancer to heart disease to rare genetic conditions—medical investigators are continually attempting to break new ground by developing better methods of ...

The FDA has cleared RevealDx’s AI-powered lung nodule risk assessment software, RevealAI-Lung, according to a company press ...

Shira Boehler shares her journey being diagnosed with Stage 1 lung cancer. A doctor explains the need for better lung cancer screening for asymptomatic, never smokers.

Background and objectives Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and effective treatment.

New robotic bronchoscopy technology at Sentara Leigh allows doctors to reach lung nodules that were previously too small or ...

Median's eyonis LCS is software is reimbursable under Medicare at a rate between $601 to $700.

Lung cancer is one of the most common cancers for men and women and by far the deadliest — it kills more people than colon, breast and prostate cancers combined. Lung cancer rates overall have been ...

Median’s eyonis LCS is being evaluated as a tool to help assess the likelihood that a lung lesion detected on low-dose CT is malignant, Oran Muduroglu, founder and CEO of Coeus Health, said in an ...

New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...

NEW ORLEANS , LA, UNITED STATES, January 29, 2026 /EINPresswire.com/ -- HeartLung Corporation announced today that ...

The National Health Services (NHS) has launched a trailblazing pilot combining artificial intelligence (AI) and robotic technology to improve the early detection and diagnosis of lung cancer. The ...

Lung cancer typically is diagnosed at a later stage than other malignancies, due to the lack of early warning indications. In 2020 it was China’s most common cancer and the leading cause of ...